Squarepoint Ops LLC Altimmune, Inc. Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

A detailed history of Squarepoint Ops LLC transactions in Altimmune, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 61,688 shares of ALT stock, worth $451,556. This represents 0.0% of its overall portfolio holdings.

Number of Shares

61,688

Holding current value

$451,556

% of portfolio

0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$5.5 - $8.1 $339,284 - $499,672	61,688 New	61,688 $378,000
Q1 2024 May 15, 2024	SELL	$8.22 - $13.81 $818,670 - $1.38 Million	-99,595 Reduced 88.31%	13,178 $134,000
Q4 2023 Feb 14, 2024	SELL	$2.14 - $11.62 $58,075 - $315,343	-27,138 Reduced 19.4%	112,773 $1.27 Million
Q2 2023 Aug 14, 2023	SELL	$3.45 - $5.97 $256,517 - $443,887	-74,353 Reduced 34.7%	139,911 $493,000
Q1 2023 May 15, 2023	BUY	$4.19 - $16.83 $897,766 - $3.61 Million	214,264 New	214,264 $904,000
Q2 2022 Aug 15, 2022	SELL	$3.94 - $11.77 $261,986 - $782,634	-66,494 Reduced 70.27%	28,133 $329,000
Q1 2022 May 16, 2022	BUY	$5.9 - $9.45 $473,451 - $758,324	80,246 Added 558.0%	94,627 $576,000
Q4 2021 Feb 14, 2022	SELL	$8.69 - $12.48 $401,712 - $576,912	-46,227 Reduced 76.27%	14,381 $132,000
Q3 2021 Nov 15, 2021	BUY	$8.43 - $16.81 $423,658 - $844,803	50,256 Added 485.47%	60,608 $685,000
Q2 2021 Aug 16, 2021	BUY	$9.85 - $16.46 $101,967 - $170,393	10,352 New	10,352 $102,000
Q4 2020 Feb 16, 2021	SELL	$7.84 - $14.22 $160,147 - $290,471	-20,427 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$9.93 - $33.26 $202,840 - $679,402	20,427 New	20,427 $270,000
Q4 2019 Feb 14, 2020	SELL	$1.53 - $2.15 $17,209 - $24,183	-11,248 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$1.95 - $2.66 $20,030 - $27,323	-10,272 Reduced 47.73%	11,248 $22,000
Q2 2019 Aug 14, 2019	SELL	$2.19 - $3.4 $27,037 - $41,976	-12,346 Reduced 36.46%	21,520 $51,000
Q1 2019 May 15, 2019	BUY	$2.54 - $4.54 $86,019 - $153,751	33,866 New	33,866 $98,000

Others Institutions Holding ALT

# of Institutions

186

Shares Held

39.3M

Call Options Held

913K

Put Options Held

743K

Black Rock Inc. New York, NY

5.32M
Shares

$39 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

4.98M
Shares

$36.5 Million
0.0% of portfolio
Ameriprise Financial Inc Minneapolis, MN

3.88M
Shares

$28.4 Million
0.01% of portfolio
State Street Corp Boston, MA

3.41M
Shares

$25 Million
0.0% of portfolio
Tang Capital Management LLC San Diego, CA

2.75M
Shares

$20.1 Million
1.44% of portfolio

View Full List

About Altimmune, Inc.

Ticker ALT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,025,300
Market Cap $359M
Description
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...

More about ALT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account